$SYRE
Spyre Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is SYRE down today? It is at $103.20 (-1.10%), and our scanner flagged it 42 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SYRE spikes, and full due diligence on SYRE — key stats, earnings, dilution and insider activity. Free.
Get free $SYRE alerts the moment volume spikes
Our scanner flagged $SYRE 42 times in the last 30 days. Create a free account to track $SYRE, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $103.20
- Change today
- -1.10%
- Previous close
- $104.35
- 52-week range
- $14.51 – $108.14
- Market cap
- $9.20B
- Institutional own.
- 99.07%
- Total held
- 99.1%
- Tradeable float
- 817K 1% of shares · after <1% insiders + 99% institutions
- Short interest
- 12.5M ▼ -8% vs prior · as of 2026-07-15
- Days to cover
- 9.0d
- Avg daily volume
- 968K
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNAS
- 5m
- 0.1x
- 15m
- 0.2x
- 1h
- 0.3x
- 1D
- 0.0x
Get free SYRE + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $SYRE down today?
SYRE is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on SYRE today.
Likely catalystSpyre Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate UpdateReported RA sub-study: Double-blind, placebo-controlled safety and efficacy study of two dose levels of SPY072 at Week 12 with open-label follow-up through Week 36. Topline proof-of-concept data are expected in September 2026.Reported PsA sub-study: Double-blind, placebo-controlled safety and efficacy study of a single dose level of SPY072 at Week 16 with open-label follow-up through Week 40. Topline proof-of-concept data are expected in the fourth quarter of 2026.Reported axSpA sub-study: Double-blind, placebo-controlled safety and efficacy study of a single dose level of SPY072 at Week 16 with open-label follow-up through Week 40. Topline proof-of-concept data are expected in the fourth quarter of 2026., from the latest SEC filing. Read it →Dilution watch
Active shelfRecent share offering + active shelf on file — the company raised capital and can raise more. If $SYRE runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- Priced at $62.00/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$SYRE Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$SYRE Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
Stocks similar to SYRE
Comparable names in pharmaceutical preparations, closest in size first.
SYRE stock FAQ
Why is $SYRE down today?
SYRE is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on SYRE today.
What is the SYRE stock price today?
SYRE last traded at $103.20, down 1.10% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live SYRE alerts?
The SYRE Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SYRE 42 times in the last 30 days.
What exchange is SYRE on?
SYRE (Spyre Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $9.20B in the PHARMACEUTICAL PREPARATIONS sector.
Is SYRE good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SYRE for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.